Jump to content

Talk:Pancreatic cancer

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
Featured articlePancreatic cancer is a featured article; it (or a previous version of it) has been identified as one of the best articles produced by the Wikipedia community. Even so, if you can update or improve it, please do so.
Main Page trophyThis article appeared on Wikipedia's Main Page as Today's featured article on June 16, 2016.
Article milestones
DateProcessResult
December 1, 2014Peer reviewReviewed
January 14, 2015Featured article candidatePromoted
In the newsA news item involving this article was featured on Wikipedia's Main Page in the "In the news" column on August 16, 2018.
Current status: Featured article


Wiki Education assignment: STS 1010

[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 11 January 2023 and 5 May 2023. Further details are available on the course page. Student editor(s): Azelenz (article contribs). Peer reviewers: LindseyWilliams42, Rsaniah, Cbrow25.

— Assignment last updated by Jessicacariello (talk) 14:57, 14 February 2023 (UTC)[reply]

Metastasis of pancreatic adenocarcinoma

[edit]

New research has been made known (Wednesday, March 22, 2023) regarding precisely how pancreatic adenocarcinoma metastasizes, featured in The Times of Israel, from the Hebrew University in Jerusalem, and published in "Nature". ([1]) ([2]) 76.16.47.132 (talk) 00:18, 28 March 2023 (UTC)[reply]

References

  1. ^ Hebrew University researchers discover how pancreatic cancer spreads through body (msn.com)
  2. ^ RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer | Nature

Potentially Good News

[edit]

Pancreatic Cancer Vaccine Shows Promise in Small Trial Ad Orientem (talk) 01:29, 11 May 2023 (UTC)[reply]

Outdated research ( and therapy?) section

[edit]

When the first case report of a woman with recurrence of pancreatic cancer successfully treated with neoantigen T-Cell receptor gene therapy (DOI: 10.1056/NEJMoa2119662) came out in June 2022, I went to this page to look at the research directions and saw that refs were on average from 2014, i.e. outdated.

Today, after publication of a series of people pancreatic cancer who personalized RNA neoantigen vaccines https://doi.org/10.1038/s41586-023-06063-y) I applied the flag " update " to the section, because it hasnt changed in a year, still the same 9 year old refs.

I think featured articles should have to lose the star in the upper right hand corner at some point. The star- notice inhibits people from editing. Wuerzele (talk) 22:55, 15 May 2023 (UTC)[reply]

Total agreement. The Pancreatic cancer#Exocrine cancer section is also stale, negligent in Immunotherapy and Targeted therapy subsections, areas have developed over the past 10 years.
See www.cancer.org/cancer/types/pancreatic-cancer/treating/immunotherapy.html
TomStonehunter (talk) 16:45, 2 February 2025 (UTC)[reply]
Followed your lead, tagged that section with the Update needed header. This appears to be the formal protest method for undeserved STARs. TomStonehunter (talk) 17:14, 2 February 2025 (UTC)[reply]

Update of Chemotherapy section

[edit]

Current section status c.2013 awaits a "head-to-head trial between" two competing chemo options. It happened. Comparison took place in a 2023 meta-analysis of 75 studies involving 11,333 participants and results published in 2024.
I plan to update last para of the chemo section accordingly.
ref: pubmed.ncbi.nlm.nih.gov/39635901 TomStonehunter (talk) 20:47, 30 January 2025 (UTC)[reply]